Zenas BioPharma’s Upsized $200 Million Series C Financing Round

Leila Ahmed
Tagged:

Wilson Sonsini Goodrich & Rosati advised SR One, Norwest Venture Partners, and Delos Capital on the transaction.Zenas BioPharma, a clinical-stage global biopharmaceutical company, announced an upsized…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here